These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8272575)

  • 1. Morphological changes in the hearts of CD1 mice following chronic treatment with doxorubicin and lonidamine.
    Sanguedolce R; Flandina C; Cucchiara T; Varvara F; Rausa L
    Res Commun Chem Pathol Pharmacol; 1993 Oct; 82(1):81-9. PubMed ID: 8272575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week.
    van Acker FA; van Acker SA; Kramer K; Haenen GR; Bast A; van der Vijgh WJ
    Clin Cancer Res; 2000 Apr; 6(4):1337-41. PubMed ID: 10778960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorative effects of ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] on the cardiotoxicity induced by doxorubicin or by isoproterenol in the mouse.
    Flandina C; Sanguedolce R; Rausa L; D'Alessandro N
    Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):259-72. PubMed ID: 2128759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of multiple treatment with doxorubicin or 4'-deoxy-doxorubicin on the DNA synthesis and morphology of mouse heart.
    Dusonchet L; Crosta L; Bellini O; Flandina C; Palmeri S; Valvo F; Rausa L
    Int J Tissue React; 1984; 6(1):81-9. PubMed ID: 6715122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin plus lonidamine: in vivo metabolic effects on the rat heart.
    Neri B; Lottini G; Bandinelli E; Cini-Neri G
    Anticancer Drugs; 1991 Aug; 2(4):401-4. PubMed ID: 1797197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-induced late cardiotoxicity: delayed impairment of Ca2+-handling mechanisms in the sarcoplasmic reticulum in the rat.
    Chugun A; Temma K; Oyamada T; Suzuki N; Kamiya Y; Hara Y; Sasaki T; Kondo H; Akera T
    Can J Physiol Pharmacol; 2000 Apr; 78(4):329-38. PubMed ID: 10772060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
    Sun X; Zhou Z; Kang YJ
    Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
    Zhou S; Starkov A; Froberg MK; Leino RL; Wallace KB
    Cancer Res; 2001 Jan; 61(2):771-7. PubMed ID: 11212281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats.
    Giri SN; Al-Bayati MA; Du X; Schelegle E; Mohr FC; Margolin SB
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):141-50. PubMed ID: 14564477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trifluoperazine does not affect doxorubicin cardiotoxicity in the rat.
    Villani F; Monti E; Piccinini F; Favalli L; Rozza Dionigi A; Lanza E; Poggi P
    Anticancer Res; 1988; 8(4):659-63. PubMed ID: 3178155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effectiveness of (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles.
    Herman EH; Ferrans VJ; Myers CE; Van Vleet JF
    Cancer Res; 1985 Jan; 45(1):276-81. PubMed ID: 3917371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological changes and catalase activity in the hearts of CD 1 mice following acute starvation or single doses of doxorubicin, epirubicin or mitoxantrone.
    Crescimanno M; Flandina C; Rausa L; Sanguedolce R; D'Alessandro N
    Chemioterapia; 1988 Feb; 7(1):53-9. PubMed ID: 3163942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.
    Tham P; Dougherty W; Iatropoulos MJ; Gordon G; James VC; Hall C; Noble JF
    Am J Pathol; 1987 Jul; 128(1):121-30. PubMed ID: 3605309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
    Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
    J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study.
    Kogan NM; Schlesinger M; Peters M; Marincheva G; Beeri R; Mechoulam R
    J Pharmacol Exp Ther; 2007 Aug; 322(2):646-53. PubMed ID: 17478614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice.
    Naidu MU; Kumar KV; Mohan IK; Sundaram C; Singh S
    Indian J Exp Biol; 2002 Aug; 40(8):894-900. PubMed ID: 12597018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
    Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
    Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein.
    Andreadou I; Papaefthimiou M; Zira A; Constantinou M; Sigala F; Skaltsounis AL; Tsantili-Kakoulidou A; Iliodromitis EK; Kremastinos DT; Mikros E
    NMR Biomed; 2009 Jul; 22(6):585-92. PubMed ID: 19308947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of the actin-myosin interaction in permeabilized cardiac trabeculae after chronic doxorubicin treatment.
    Bottone AE; Voest EE; de Beer EL
    Clin Cancer Res; 1998 Apr; 4(4):1031-7. PubMed ID: 9563899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.